References
- Warde P, Jewett MA. Surveillance for stage I testicular seminoma. Is it a good option? Urol Clin North Am 1998; 25: 425–33.
- Klepp O, Dahl O, Flodgren P, et al. Risk-adapted treatment of clinical stage I non-seminomatous testis cancer. Eur J Cancer 1997; 33: 1038–44.
- Sternberg CN. The management of stage I testis cancer. Urol Clin North Am 1998; 25: 435–49.
- Horwich A. Questions in the management of seminoma. Clin Oncol 1990; 2: 249–53.
- Raghavan D. Active surveillance" for stage 1 testis cancer: attaining maturity at 21 years. Eur J Cancer 2000; 36: 1891–4.
- Fossa A, Fossa SD. Serum lactatedehydrogenase and human choriogonadotrophin in seminoma. Br J Urol 1984; 63: 408–15.
- Cooper EH. Neuron-specific enolase. Int J Biol Mark 1994; 9: 205–10.
- Niehans GA, Manivel C, Copland GT, Scheithauer BW, Wick MR. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 1988; 62: 1113–23.
- Fossa SD, Klepp O, Paus E. Neuron-specific enolase—a serum tumour marker in seminoma? Br J Cancer 1992; 65: 297–9.
- Kuzmits R, Schernthaner G, Krisch K. Serum neuron-specific enolase—a marker for response to therapy in seminoma. Cancer 1987; 60: 1017–21.
- Gross AJ, Dieckmann KR Neuron-specific enolase: a serum tumor marker in malignant germ-cell tumors? Eur Urol 1993; 24: 277–8.
- Horwich A, Brada M, Nicholls J, et al. Intensive induction chemotherapy for poor risk nonseminomatous germ cell tumours. Eur J Cancer 1989; 25: 177–84.
- Giovanella L, Ceriani L, Bandera M, Garancini S. Immunor-adiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase. Int J Biol Mark 2001; 16: 50–5.